Multiple Sclerosis: Clinical Advances in Diagnosis and Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 155
Special Issue Editor
Interests: multiple sclerosis; autism spectrum disorders; child and adolescent psychiatry; developmental disabilities; cognitive development; psychopathology
Special Issue Information
Dear Colleagues,
This Special Issue seeks to explore the latest clinical advances in the diagnosis and treatment of multiple sclerosis, a complex neurological disorder that significantly impacts patients' lives. As research progresses, it is crucial to integrate new diagnostic techniques and therapeutic strategies that enhance patient care and outcomes.
We invite submissions that focus on innovative diagnostic tools, such as advanced neuroimaging and biomarker development, as well as emerging therapies, including disease-modifying treatments and personalized medicine approaches. This Special Issue aims to provide a platform for sharing cutting-edge research and expert insights that can help clinicians navigate the evolving landscape of multiple sclerosis care.
Contributors are encouraged to submit original research, reviews, and perspectives that address current challenges and future directions in multiple sclerosis diagnosis and treatment. Our goal is to foster a comprehensive understanding of the advancements that can ultimately improve the quality of life for individuals living with multiple sclerosis.
Dr. Marta Simone
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- relapse-remitting multiple sclerosis
- progressive multiple sclerosis
- immunomodulatory treatments
- cognitive impairment
- personalized medicine in multiple sclerosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
